http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PH-12016501898-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b70512b2076a2759fccaecf9fe962d5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
filingDate 2016-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_433c48591228ab16dff64c46b76b7f35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f0db66154556dbe7975033ea577843f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d4bcf92b4edfdc3201050c6f116762a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_530966361ce2c0dd2e556076a5dbe2ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b19ecc4a0bbcb18ecfb12cf8b6225af
publicationDate 2017-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PH-12016501898-B1
titleOfInvention Quinoxaline derivatives useful as fgfr kinase modulators
abstract The invention relates to new quinoxaline derivative compounds to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
priorityDate 2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457489092

Total number of triples: 22.